PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system on nociceptors to treat pain.[1] The company was established in 2004 through the merger of two academic spinout firms: Antalium from McGill University and NeuroCeptor from Queens University.[2][3] At its inception, the company's primary operations were in Montreal and Kingston,[3] and it established a partnership with the Danish company NeuroSearch as part of its birth.[4]